Genvivo Revenue, Growth & Competitor Profile

DBA EPEIUS BIOTECHNOLOGIES CORPORATION

Company Profile & Annual Report for Genvivo

Access the complete profile.

Genvivo Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	475 Huntington Drive San Marino, CA 91108

Note: Revenues for privately held companies are statistical evaluations.


Genvivo's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Genvivo's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Genvivo is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Genvivo Annual Revenue and Growth Rate

Genvivo	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Genvivo's revenues are gauged from an analysis of company filings.

Genvivo's Income Statement (based on Industry Averages)

Genvivo P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Genvivo has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 23, 2009	1	2%	$14 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Genvivo is developing and marketing. Genvivo doesn't have any recent trademark applications, indicating Genvivo is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
GENVIVO Pharmaceutical products for the treatment of cancer	12/07/2021
GENEVIEVE PROTOCOL Medical services featuring a clinical protocol wherein two distinct tumor-targeted gene vectors, one carrying a cytocidal gene (a mutated cyclin G1), and the other bearing an immunomodulatory cytokine gene (GM-CSF), are used in combination for cancer immunotherapy or cancer vaccination	02/06/2008

See all trademarks and details in the Full Report.

Market Share of Genvivo's Largest Competitors

A competitive analysis shows these companies are in the same general field as Genvivo, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Genvivo. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
DOHENY EYE INSTITUTE	Pasadena, CA	100
GMTO	Pasadena, CA	50
GENVIVO	San Marino, CA	36
HUNTINGTON MEDICAL RESEARCH INSTITUTES	Pasadena, CA	22
EMBODIED	Pasadena, CA	15
AGOURON INSTITUTE	Pasadena, CA	11

Future Competition: Genvivo's Fastest Growing Competitors

These companies are in the same general field as Genvivo and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)